Trial Profile
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active-Controlled Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Oliceridine (Primary) ; Morphine
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Acronyms APOLLO-2
- Sponsors Trevena
- 08 Dec 2022 According to a Trevena media release, data from this study were presented at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting.
- 10 Aug 2021 Exploratory analysis of data from APOLLO-1 and APOLLO-2 trials published in the Trevena Media Release.
- 10 Aug 2021 According to a Trevena media release, exploratory analysis of data from APOLLO-1 and APOLLO-2 trials with lead author Gregory B. Hammer published in the Journal of Pain and Therapy.